Search filters

Filters
Clear All

Phase

  • 5
  • 3
  • 4
  • 5
  • 2
  • 50
  • 73
  • 37
  • 1
  • 7
  • 65

Found 73 Lymphocytic Leukemia, Acute trials

A listing of Lymphocytic Leukemia, Acute medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years and younger
All genders
Phase 4
The primary study objective is to evaluate the rate of durable remission of relapsing disease activity, assessed serially both clinically and by MRI, from randomization through 48 months in participants with early relapsing multiple sclerosis who discontinue OCR after 12 and 24 months of treatment. Secondary objectives include: - Mechanistic: …
 HERMES: Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
18-100 years
All genders
Phase 3
This study will determine if ziltivekimab, a monoclonal antibody, can be used to treat people living with heart failure and inflammation. Previous studies showed that ziltivekimab can lower inflammation, which may have a positive effect on heart failure symptoms. The HERMES study will look more into this effect. Also, the …
18 years and older
Female
Millions of women worldwide have accidental leakage of urine they cannot control after giving birth. Dealing with this problem can be embarrassing and can even add to feelings of anxiety or depression. If you are experiencing this sort of bothersome accidental bladder leakage, the University of Pennsylvania Health System care …
18-45 years
All genders
Join the largest, long-term nationwide study that hopes to better understand baby brain development. Leading researchers in the fields of child development and neuroscience will work with participating families and their children to understand how the brain develops and is affected by exposure to substances and other environmental, social, and …
18-99 years
Female
Phase 2
This research study is being done to study the safety and toxicity of proton whole pelvis radiation, a type of external beam radiation treatment, for gynecologic cancers after surgery. Currently, for such gynecology cancers, Image- guided Intensity Modulated Radiation Therapy (IG-IMRT) is being done after hysterectomy as the standard treatment. …
 Study to Investigate the Efficacy and Safety of NS-229 in the Treatment of EGPA
18-90 years
All genders
Phase 2
The main purpose of this study is to learn how well the investigational drug NS-229 works and how safe NS-229 is compared with placebo.  An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA) to treat EGPA.   Participants could be in the …
 Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG
18-99 years
All genders
The overall objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery.
 The Influence of Haptic Communication on Healthy and Impaired Human Motor Learning of a Robot-Based Task
18-100 years
Accepts healthy volunteer
All genders
This study looks at how people learn to do things with robots. We want to see if it’s easier to learn when you work with someone else or when you do it by yourself. We are also interested in how different people with different physical and thinking abilities learn these …
99 years and younger
All genders
The research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these patterns with transcranial magnetic stimulation (TMS). First, we will use functional Magnetic Resonance Imaging (fMRI) data to generate a negative affect map for each subject. Then, we will …
99 years and younger
All genders
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from …